These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 8204504)
81. A two unit antisense RNA cassette test system for silencing of target genes. Engdahl HM; Hjalt TA; Wagner EG Nucleic Acids Res; 1997 Aug; 25(16):3218-27. PubMed ID: 9241234 [TBL] [Abstract][Full Text] [Related]
82. Gene silencing of HIV chemokine receptors using ribozymes and single-stranded antisense RNA. Qureshi A; Zheng R; Parlett T; Shi X; Balaraman P; Cheloufi S; Murphy B; Guntermann C; Eagles P Biochem J; 2006 Mar; 394(Pt 2):511-8. PubMed ID: 16293105 [TBL] [Abstract][Full Text] [Related]
83. Cell-type-specific aptamer and aptamer-small interfering RNA conjugates for targeted human immunodeficiency virus type 1 therapy. Zhou J; Rossi J J Investig Med; 2014 Oct; 62(7):914-9. PubMed ID: 25118114 [TBL] [Abstract][Full Text] [Related]
84. Effective inhibition of herpes simplex virus 1 gene expression and growth by engineered RNase P ribozyme. Trang P; Lee J; Kilani AF; Kim J; Liu F Nucleic Acids Res; 2001 Dec; 29(24):5071-8. PubMed ID: 11812839 [TBL] [Abstract][Full Text] [Related]
85. Differential effects of the protein cofactor on the interactions between an RNase P ribozyme and its target mRNA substrate. Hsu AW; Kilani AF; Liou K; Lee J; Liu F Nucleic Acids Res; 2000 Aug; 28(16):3105-16. PubMed ID: 10931926 [TBL] [Abstract][Full Text] [Related]
86. Ribozyme as an approach for growth suppression of human pancreatic cancer. Kijima H; Scanlon KJ Mol Biotechnol; 2000 Jan; 14(1):59-72. PubMed ID: 10911615 [TBL] [Abstract][Full Text] [Related]
87. UV cross-link mapping of the substrate-binding site of an RNase P ribozyme to a target mRNA sequence. Kilani AF; Liu F RNA; 1999 Sep; 5(9):1235-47. PubMed ID: 10496224 [TBL] [Abstract][Full Text] [Related]
88. Antigene, ribozyme and aptamer nucleic acid drugs: progress and prospects. Stull RA; Szoka FC Pharm Res; 1995 Apr; 12(4):465-83. PubMed ID: 7596980 [TBL] [Abstract][Full Text] [Related]
89. Exploring the use of antisense, enzymatic RNA molecules (ribozymes) as therapeutic agents. Rossi JJ; Elkins D; Taylor N; Zaia J; Sullivan S; Deshler JO Antisense Res Dev; 1991; 1(3):285-8. PubMed ID: 1821650 [TBL] [Abstract][Full Text] [Related]
90. Gene therapeutic agents: the use of ribozymes, antisense, and RNA decoys for HIV-1 infection. Smythe JA; Symonds G Inflamm Res; 1995 Jan; 44(1):11-5. PubMed ID: 7664023 [No Abstract] [Full Text] [Related]
91. Catalytic antisense RNA (ribozymes): their potential and use as anti-HIV-1 therapeutic agents. Rossi JJ; Sarver N Adv Exp Med Biol; 1992; 312():95-109. PubMed ID: 1514448 [No Abstract] [Full Text] [Related]